Stefan Kustermann
Roche (Switzerland)(CH)
Publications by Year
Research Areas
Retinal Development and Disorders, 3D Printing in Biomedical Research, Pluripotent Stem Cells Research, Retinal Diseases and Treatments, Microfluidic and Bio-sensing Technologies
Most-Cited Works
- → Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 ( SMN2 ) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA)(2018)505 cited
- → Membrane-free culture and real-time barrier integrity assessment of perfused intestinal epithelium tubes(2017)286 cited
- → Human-Induced Pluripotent Stem Cells Generate Light Responsive Retinal Organoids with Variable and Nutrient-Dependent Efficiency(2018)198 cited
- → A label-free, impedance-based real time assay to identify drug-induced toxicities and differentiate cytostatic from cytotoxic effects(2012)92 cited
- → Minimizing DILI risk in drug discovery — A screening tool for drug candidates(2015)88 cited
- → https://www.altex.org/index.php/altex/article/view/1339(2019)75 cited
- → In vitro teratogenicity testing using a 3D, embryo-like gastruloid system(2021)66 cited
- → Organ-on-a-chip technologies that can transform ophthalmic drug discovery and disease modeling(2018)56 cited
- → Human Retinal Organoids Provide a Suitable Tool for Toxicological Investigations: A Comprehensive Validation Using Drugs and Compounds Affecting the Retina(2022)49 cited
- → Human Retinal Microvasculature‐on‐a‐Chip for Drug Discovery(2020)48 cited